Sucampo Revenues Up $SCMP $XHS

Sucampo Pharmaceuticals, Inc., has announced financial results for the first quarter of 2015.

The results shows 33% Rise in Revenues Totaling $29.5 Million, whereas EPS was $0.14.

View the full earnings release here.